Civil-military cooperation to contain COVID-19 epidemic in Israel- Lesson learned: Zohar Mor

por Mor, Z, Davidi, N, Alroy Preis, S
Publicado 2022

The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries

por Waitzberg, Ruth, Triki, Noa, Alroy-Preis, Sharon, Lotan, Tomer, Shiran, Liat, Ash, Nachman
Publicado 2021

Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2

por Lustig, Yaniv, Nemet, Ital, Kliker, Limor, Zuckerman, Neta, Yishai, Ruti, Alroy-Preis, Sharon, Mendelson, Ella, Mandelboim, Michal
Publicado 2021

Protection against Covid-19 by BNT162b2 Booster across Age Groups

por Bar-On, Yinon M., Goldberg, Yair, Mandel, Micha, Bodenheimer, Omri, Freedman, Laurence, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit, Milo, Ron
Publicado 2021

Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine

por Amir, Ofra, Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Ash, Nachman, Alroy-Preis, Sharon, Huppert, Amit, Milo, Ron
Publicado 2022

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2

por Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Freedman, Laurence S., Ash, Nachman, Alroy-Preis, Sharon, Huppert, Amit, Milo, Ron
Publicado 2022

BNT162b2 vaccine effectiveness was marginally affected by the SARS-CoV-2 beta variant in fully vaccinated individuals

por Mor, Orna, Zuckerman, Neta S., Hazan, Itay, Fluss, Ronen, Ash, Nachman, Ginish, Netanel, Mendelson, Ella, Alroy-Preis, Sharon, Freedman, Laurence, Huppert, Amit
Publicado 2022

Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster

por Amir, Ofra, Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Freedman, Laurence, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit, Milo, Ron
Publicado 2023

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel

por Bar-On, Yinon M., Goldberg, Yair, Mandel, Micha, Bodenheimer, Omri, Amir, Ofra, Freedman, Laurence, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit, Milo, Ron
Publicado 2022

Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study

por Amir, Ofra, Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M, Bodenheimer, Omri, Freedman, Laurence, Ash, Nachman, Alroy-Preis, Sharon, Huppert, Amit, Milo, Ron
Publicado 2023

Waning Immunity after the BNT162b2 Vaccine in Israel

por Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Freedman, Laurence, Haas, Eric J., Milo, Ron, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit
Publicado 2021

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

por Lustig, Yaniv, Zuckerman, Neta, Nemet, Ital, Atari, Nofar, Kliker, Limor, Regev-Yochay, Gili, Sapir, Einav, Mor, Orna, Alroy-Preis, Sharon, Mendelson, Ella, Mandelboim, Michal
Publicado 2021

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

por Bar-On, Yinon M., Goldberg, Yair, Mandel, Micha, Bodenheimer, Omri, Freedman, Laurence, Kalkstein, Nir, Mizrahi, Barak, Alroy-Preis, Sharon, Ash, Nachman, Milo, Ron, Huppert, Amit
Publicado 2021

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection

por Nemet, Ital, Kliker, Limor, Lustig, Yaniv, Zuckerman, Neta, Erster, Oran, Cohen, Carmit, Kreiss, Yitshak, Alroy-Preis, Sharon, Regev-Yochay, Gili, Mendelson, Ella, Mandelboim, Michal
Publicado 2021

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel

por Reicher, Shay, Ratzon, Ronit, Ben-Sahar, Shay, Hermoni-Alon, Sharon, Mossinson, David, Shenhar, Yotam, Friger, Michael, Lustig, Yaniv, Alroy-Preis, Sharon, Anis, Emilia, Sadetzki, Siegal, Kaliner, Ehud
Publicado 2021

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

por Mevorach, Dror, Anis, Emilia, Cedar, Noa, Hasin, Tal, Bromberg, Michal, Goldberg, Lital, Parnasa, Elchanan, Dichtiar, Rita, Hershkovitz, Yael, Ash, Nachman, Green, Manfred S., Keinan-Boker, Lital, Alroy-Preis, Sharon
Publicado 2022

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022

por Kliker, Limor, Zuckerman, Neta, Atari, Nofar, Barda, Noam, Gilboa, Mayan, Nemet, Ital, Abd Elkader, Bayan, Fratty, Ilana S, Jaber, Hanaa, Mendelson, Ella, Alroy-Preis, Sharon, Kreiss, Yitshak, Regev-Yochay, Gili, Mandelboim, Michal
Publicado 2022

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Isra...

por Haas, Eric J, Angulo, Frederick J, McLaughlin, John M, Anis, Emilia, Singer, Shepherd R, Khan, Farid, Brooks, Nati, Smaja, Meir, Mircus, Gabriel, Pan, Kaijie, Southern, Jo, Swerdlow, David L, Jodar, Luis, Levy, Yeheskel, Alroy-Preis, Sharon
Publicado 2021

Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveilla...

por Haas, Eric J, McLaughlin, John M, Khan, Farid, Angulo, Frederick J, Anis, Emilia, Lipsitch, Marc, Singer, Shepherd R, Mircus, Gabriel, Brooks, Nati, Smaja, Meir, Pan, Kaijie, Southern, Jo, Swerdlow, David L, Jodar, Luis, Levy, Yeheskel, Alroy-Preis, Sharon
Publicado 2022

Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study

por Singer, Shepherd R., Angulo, Frederick J., Swerdlow, David L., McLaughlin, John M., Hazan, Itay, Ginish, Netanel, Anis, Emilia, Mendelson, Ella, Mor, Orna, Zuckerman, Neta S, Erster, Oran, Southern, Jo, Pan, Kaijie, Mircus, Gabriel, Lipsitch, Marc, Haas, Eric J., Jodar, Luis, Levy, Yeheskel, Alroy-Preis, Sharon
Publicado 2021